2-((6-(Chloromethyl)pyridin-2-yl)methyl)isoindoline-1,3-dione
95%
- Product Code: 162338
CAS:
628308-52-1
Molecular Weight: | 286.71 g./mol | Molecular Formula: | C₁₅H₁₁ClN₂O₂ |
---|---|---|---|
EC Number: | MDL Number: | MFCD28159324 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C |
Product Description:
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of targeted protein degradation therapies such as PROTACs (proteolysis targeting chimeras). Its structure allows for effective linker functionality, connecting E3 ligase ligands to target protein binders, enabling the degradation of disease-causing proteins. Commonly employed in medicinal chemistry research for constructing bifunctional molecules with improved binding and pharmacokinetic properties.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.100 G | 10-20 days | ฿12,800.00 |
+
-
|
0.250 G | 10-20 days | ฿15,030.00 |
+
-
|
1.000 G | 10-20 days | ฿56,000.00 |
+
-
|
2-((6-(Chloromethyl)pyridin-2-yl)methyl)isoindoline-1,3-dione
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of targeted protein degradation therapies such as PROTACs (proteolysis targeting chimeras). Its structure allows for effective linker functionality, connecting E3 ligase ligands to target protein binders, enabling the degradation of disease-causing proteins. Commonly employed in medicinal chemistry research for constructing bifunctional molecules with improved binding and pharmacokinetic properties.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :